ABBAS MEDICAL CONSULTANCY LIMITED
Opportunity 75/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (80/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Sector-multiple EBITDA, turnover, and NAV-proxy valuation range with confidence tier — derived from extracted iXBRL financials.
Available from the Pro tier upwards.
See pricing →Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-08-31 | 2024-08-31 |
|---|---|---|
| Profit before tax | £12.5k | — |
| Average employees | 200 | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 persons-with-significant-control
- • 1 persons-with-significant-control
- • 1 accounts
- • 1 persons-with-significant-control
- • 1 accounts
Corporate timeline (21 events)Click to expand
- 2026-05-18📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2026-05-12📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-05-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-05-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-03-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-04-15📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-04-20📄change-person-director-company-with-change-dateofficers · CH01
- 2021-04-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-05-07📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-03-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-04-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-08-28📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2017-08-28📄change-person-director-company-with-change-dateofficers · CH01
- 2017-05-06📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-04-17📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2009-08-14🏢Company incorporatedAs ABBAS MEDICAL CONSULTANCY LIMITED
- 2009-08-14➕ABBAS, Syed Nadeem, Dr appointeddirector
- 2009-08-14➕ABERGAN REED NOMINEES LIMITED appointedcorporate-secretary
- 2009-08-14➖ABERGAN REED NOMINEES LIMITED resignedcorporate-secretary
- 2009-08-14➕PELLATT, Christopher Michael appointeddirector
- 2009-08-14➖PELLATT, Christopher Michael resigneddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "ABBAS" — strong identity link between founder and business.
- +Long-tenure founder: Senior director has been in place 17 years — deep operational knowledge concentrated in one person.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 17 years.
- secondaryStable-but-static management: Company is 17 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Naddem Abbas Individual · British · DOB 06/1976 · age 50 | 75–100% | 75–100% | 75-100% shares · 75-100% voting | 01/08/2017 |
1 historic (ceased) PSC
- Dr Nadeem Abbasceased 18/05/2026· 75-100% shares · 75-100% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · IG postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A B M GROUPER LIMITED→ 02503260 · est 1990 · no financials extracted | — | — | — | — | 35y | — | — |
| A69 LIMITED→ 15289132 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AA AND ISHAA LIMITED→ 13494922 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AA MEDICS LIMITED→ 11752708 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AA SIGHT LTD→ 13405038 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AANCHAL WOMEN'S AID LTD.→ 05516915 · est 2005 · no financials extracted | — | — | — | — | 20y | — | — |
| AARK HEALTH LIMITED→ 14307418 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AARON SAUND LTD→ 16848177 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AAVON CARE LIMITED→ 16819854 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AB ENT SERVICES LIMITED→ 07264660 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| ABBASI MEDICAL ALLIANCE LTD→ 15953253 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ABBEY CARE CENTRE LIMITED→ 05741454 · est 2006 · no financials extracted | — | — | — | — | 20y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 2 resigned)
Click a director name to see their full track record across all companies.